Protagonist Therapeutics Inc.
PTGX
|
|
| |
|
| Trading Volume | 11,039 |
|
|
42.74 - 14.05 |
| Market Cap Full | $ 2.4B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 2.6% | 26% | 110.8% | -30.8% |
| Q2 | - | 20.7% | 20.1% | -66.6% |
| Q3 | - | 13.1% | -39.6% | 6.6% |
| Q4 | - | -4.8% | 40.3% | 29.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.6 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 9.1 | 21.5 | -4.9 | -11.4 | 9.9 | 21.1 | 9.7 | 13.1 | - | - | - | - |
| 2023 | |||||||||||
| 21.8 | 22.1 | 41.8 | -1.7 | 15.4 | 6 | -29.8 | 2.2 | -15.8 | -12.8 | 25.2 | 25.9 |
| 2022 | |||||||||||
| -14.4 | -14.7 | -5.2 | -61 | -5.1 | -9.7 | 25.8 | -12.4 | -3.3 | -3.9 | -2.4 | 37.9 |
| 2021 | |||||||||||
| 4.7 | 13.4 | 9.9 | 12.6 | 20.4 | 27.8 | 10.1 | -1.9 | -63.5 | 78.7 | 6.2 | 1.7 |
| 2020 | |||||||||||
| 4.5 | 7.1 | -9.7 | -4.4 | 144.9 | 6.8 | -10.9 | 42.4 | -12.7 | -3.1 | 25.8 | -16.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.7 | -0.4 | -0.5 | -0.7 |
| Q2 | -0.7 | -0.8 | -0.7 | -0.6 |
| Q3 | -0.6 | -0.6 | -0.7 | -0.2 |
| Q4 | 0 | -0.7 | -0.8 | -0.4 |
| A | -1.93 | -2.6 | -2.7 | -1.9 |